Matches in SemOpenAlex for { <https://semopenalex.org/work/W2428011462> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2428011462 endingPage "212" @default.
- W2428011462 startingPage "207" @default.
- W2428011462 abstract "BACKGROUND AND PURPOSE In the pathomechanism of multiple sclerosis (MS), a vital role is attributed to autoimmune responses. Higher activity of the disease is connected with an increased activity of proinflammatory cytokines while in remissions anti-inflammatory cytokines dominate. The aim of the study was to evaluate the effects of methylprednisolone treatment on the level of IL-4 and IL-12 and to determine whether their levels are related to the degree of disability and may be prognostic factors in the assessment of relapse sequelae. MATERIAL AND METHODS The study included 32 patients with MS (according to McDonald's criteria) with relapses and remissions (17 patients with relapse who received methylprednisolone in the dose of 1.0 g i. v. on 5 consecutive days and 15 patients in remission). The control group consisted of 15 patients with non-inflammatory diseases of the nervous system. The levels of cytokines were determined by ELISA method using the Pharmingen kits. The examinations of patients in relapse were conducted before and after steroid therapy; the remaining patients were examined only once. RESULTS In the relapse a visible increase in serum IL-12 level (p<0.05) was observed; its level after methylprednisolone treatment was found to be significantly decreased (p<0.001). The level of IL-4 was not significantly affected by steroid therapy. There was no relation between the severity of disability and cytokine levels. CONCLUSIONS The level of IL-12 increases in MS relapses and decreases after methylprednisolone therapy. The changes in IL-4 and IL-12 levels are the manifestations of inflammatory reactions connected with the relapse; however, they do not directly indicate the extent of damage to CNS. They cannot be treated as a prognostic factor allowing to anticipate the consequences of the relapse." @default.
- W2428011462 created "2016-06-24" @default.
- W2428011462 creator A5038611232 @default.
- W2428011462 creator A5052084882 @default.
- W2428011462 creator A5073954683 @default.
- W2428011462 creator A5085727234 @default.
- W2428011462 date "2005-05-01" @default.
- W2428011462 modified "2023-10-05" @default.
- W2428011462 title "[Change of interleukin-4 and interleukin-12 levels after therapy of multiple sclerosis relapse with methylprednisolone]." @default.
- W2428011462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15981158" @default.
- W2428011462 hasPublicationYear "2005" @default.
- W2428011462 type Work @default.
- W2428011462 sameAs 2428011462 @default.
- W2428011462 citedByCount "1" @default.
- W2428011462 countsByYear W24280114622023 @default.
- W2428011462 crossrefType "journal-article" @default.
- W2428011462 hasAuthorship W2428011462A5038611232 @default.
- W2428011462 hasAuthorship W2428011462A5052084882 @default.
- W2428011462 hasAuthorship W2428011462A5073954683 @default.
- W2428011462 hasAuthorship W2428011462A5085727234 @default.
- W2428011462 hasConcept C126322002 @default.
- W2428011462 hasConcept C164027704 @default.
- W2428011462 hasConcept C203014093 @default.
- W2428011462 hasConcept C2776914184 @default.
- W2428011462 hasConcept C2778690821 @default.
- W2428011462 hasConcept C2779134260 @default.
- W2428011462 hasConcept C2780372218 @default.
- W2428011462 hasConcept C2780640218 @default.
- W2428011462 hasConcept C71924100 @default.
- W2428011462 hasConcept C74172505 @default.
- W2428011462 hasConcept C90924648 @default.
- W2428011462 hasConceptScore W2428011462C126322002 @default.
- W2428011462 hasConceptScore W2428011462C164027704 @default.
- W2428011462 hasConceptScore W2428011462C203014093 @default.
- W2428011462 hasConceptScore W2428011462C2776914184 @default.
- W2428011462 hasConceptScore W2428011462C2778690821 @default.
- W2428011462 hasConceptScore W2428011462C2779134260 @default.
- W2428011462 hasConceptScore W2428011462C2780372218 @default.
- W2428011462 hasConceptScore W2428011462C2780640218 @default.
- W2428011462 hasConceptScore W2428011462C71924100 @default.
- W2428011462 hasConceptScore W2428011462C74172505 @default.
- W2428011462 hasConceptScore W2428011462C90924648 @default.
- W2428011462 hasIssue "3" @default.
- W2428011462 hasLocation W24280114621 @default.
- W2428011462 hasLocation W24280114622 @default.
- W2428011462 hasOpenAccess W2428011462 @default.
- W2428011462 hasPrimaryLocation W24280114621 @default.
- W2428011462 hasRelatedWork W1902363840 @default.
- W2428011462 hasRelatedWork W1971181731 @default.
- W2428011462 hasRelatedWork W1973555557 @default.
- W2428011462 hasRelatedWork W2067933361 @default.
- W2428011462 hasRelatedWork W2077990172 @default.
- W2428011462 hasRelatedWork W2082743251 @default.
- W2428011462 hasRelatedWork W2110846541 @default.
- W2428011462 hasRelatedWork W2187447678 @default.
- W2428011462 hasRelatedWork W2339722902 @default.
- W2428011462 hasRelatedWork W2342716718 @default.
- W2428011462 hasRelatedWork W2602821845 @default.
- W2428011462 hasRelatedWork W2731577211 @default.
- W2428011462 hasRelatedWork W2791507333 @default.
- W2428011462 hasRelatedWork W2889340395 @default.
- W2428011462 hasRelatedWork W2890577848 @default.
- W2428011462 hasRelatedWork W2952594575 @default.
- W2428011462 hasRelatedWork W3019615993 @default.
- W2428011462 hasRelatedWork W3029324504 @default.
- W2428011462 hasRelatedWork W3094772596 @default.
- W2428011462 hasRelatedWork W3168183011 @default.
- W2428011462 hasVolume "39" @default.
- W2428011462 isParatext "false" @default.
- W2428011462 isRetracted "false" @default.
- W2428011462 magId "2428011462" @default.
- W2428011462 workType "article" @default.